Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients

NCT02042690

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Aerospace Center Hospital Beijing, Beijing Municipality, China
  • Wuhan Union Hospital Wuhan, Hubei, China
  • The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • General Hospital of PLA Beijing, China
View Trial Details
Completed

Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

NCT00275054

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Universitaetsklinik fuer Innere Medizin I Vienna, Austria
  • Centre Hospitalier Universitaire d'Amiens Amiens, France
  • Centre Hospitalier Regional et Universitaire d'Angers Angers, France
  • Centre Hospitalier Victor Dupouy Argenteuil, France
View all 91 locations
View Trial Details
Completed

Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT00262795

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hanuschkrankenhaus Vienna, Austria
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Zentralklinikum Augsburg Augsburg, Germany
View all 88 locations
View Trial Details
Completed

Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia

NCT00276848

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria
  • Hanuschkrankenhaus Vienna, Austria
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Internistische Praxis - Arnstadt Arnstadt, Germany
View all 135 locations
View Trial Details
Completed

Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia

NCT00274989

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Internistische Praxis - Arnstadt Arnstadt, Germany
  • Klinikum Augsburg Augsburg, Germany
  • HELIOS Klinikum Bad Saarow Bad Saarow, Germany
  • Internistische Gemeinschaftspraxis - Berlin Berlin, Germany
View all 58 locations
View Trial Details
Completed

Comparison Of 2 Doses Of Temsirolimus (Torisel) In Patients With Mantle Cell Lymphoma

NCT01180049

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Mercy Research Institute Miami, Florida, United States
  • Veterans Affairs New Jersey Healthcare System-Hematology/Oncology Section (111) East Orange, New Jersey, United States
  • Mercy Clinic Oklahoma Communities dba Mercy Clinic Oncology/Hematology-McAuley Oklahoma City, Oklahoma, United States
  • Mercy Hospital Oklahoma City-Oncology Infusion Oklahoma City, Oklahoma, United States
View all 31 locations
View Trial Details
Completed

Study of the Combination of AFM13 and Pembrolizumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

NCT02665650

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
View all 18 locations
View Trial Details

Related conditions